Traveling ‘green’ – lessons from London to Switzerland, via train

Submitted by Alana on Tue, 01/03/2022 - 17:05

As a company, we’ve changed our approach to travel. 

Working in an industry that favors face-to-face meetings for effective scientific exchange, train travel, wherever feasible, is one way in which the AS&K group is reducing its environmental impact. And it’s one reason why we were recognized as one of Europe’s Climate Leaders 2022 by the Financial Times. 

Saying Goodbye to Gynecological Cancer

Submitted by admin on Tue, 01/03/2022 - 15:03

Just two years after my older sister had been diagnosed with cervical cancer, I was given the news that I had both ovarian and uterine cancer. Of the five types of gynecological cancer – vulval and vaginal being the other two – my sister and I had three. It was a huge blow and something that, as a family, we felt ill-prepared for. I subsequently underwent a double oophorectomy and a full hysterectomy, surgical procedures involving removal of my womb and both of my ovaries, which left me struggling with the symptoms of surgical menopause as well as the side effects of chemotherapy.

The changing landscape of epilepsy treatments: what does the future hold?

Submitted by krupa.mistry on Mon, 21/02/2022 - 11:29

Epilepsy affects approximately 50 million people worldwide and The WHO estimates that up to 70% (1) of them could live seizure-free if properly diagnosed and treated. Epilepsy is a chronic disease of the central nervous system which affects people of all ages, ethnicities, locations and socio-economic backgrounds.